Maximum quantity allowed is 999
请选择数量
CAS RN: 67330-25-0 | 產品號碼: B5391
Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate
纯度/分析方法: >98.0%(HPLC)(N)
別名
- N-(3-Trifluoromethylphenyl)anthranilic Acid Butyl Ester
- Butyl Flufenamate
- Flufenamic Acid Butyl Ester
- Butyl N-(3-Trifluoromethylphenyl)anthranilate
- 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid Butyl Ester
- Ufenamate
文件:
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品規格
Appearance | Colorless to Yellow clear liquid |
Purity(HPLC) | min. 98.0 area% |
Purity(with Total Nitrogen) | min. 98.0 % |
NMR | confirm to structure |
性質
沸點 | 170 °C/1 mmHg |
flp | 192 °C |
比重 | 1.21 |
折射率 | 1.56 |
GHS
圖形表示 | |
信號詞 | Warning |
危險性說明 | H302 : Harmful if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
RTECS # | DH8511000 |
運輸資料
HS編碼* | 2922.49-000 |
Application
Butyl Flufenamate: A Lipophilic Prodrug of Flufenamic Acid
Butyl flufenamate (ufenamate or HF-264) is a lipophilic prodrug of flufenamic acid [T2351]. It is reported that butyl flufenamate inhibits the synthesis of prostaglandin E1, but its inhibition is weaker than that of flufenamic acid. Its ointment is used topically for the treatment of eczema and atopic dermatitis in clinical use. (The product is for research purpose only.)
References
- Penetration of ufenamate into intact, stripped, or delipidized skin using different vehicles
- High-performance liquid chromatographic assay of antiinflammatory drugs incorporated in gel ointments. Separation and stability testing
考研文獻
文章/手冊
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。